Infectious Diseases
Outbreaks, vaccines, and practical infectious disease guidance.
Evidence-based content on metabolic health, chronic disease, and everyday health decisions — no fluff, no sensationalism.
Browse All GuidesCurated topic hubs — rotates weekly
Outbreaks, vaccines, and practical infectious disease guidance.
Stroke, TIA, emergency neurology, and brain health.
Anxiety, depression, ADHD, sleep, and evidence-based care.
Weight, insulin resistance, GLP-1s, and cardiometabolic risk.
Most GLP-1 patients stop within a year. Here's why adherence — not efficacy — is the defining challenge in metabolic therapy.
A new BMJ Medicine study suggests stopping GLP-1 drugs may quickly erase their cardiovascular benefits.
New hypertension guidelines are changing who gets treated. Here's what it means in 2026.
For years, moderate drinking was thought to be healthy. Newer research is challenging that idea.
From GLP-1 weight-loss drugs to experimental recovery compounds, these peptides are driving the biggest conversations in longevity and metabolic medicine.
Recently updated health guides
The 2025 AHA/ACC guideline emphasizes prevention, early treatment, pregnancy care, and brain health in managing high blood pressure.
How alcohol affects cancer risk, heart health, and long-term disease prevention.
An overview of MOTS-c, a mitochondrial-derived peptide studied in metabolism and aging research, including evidence limitations, regulatory status, and safety considerations.
A medical overview of oxytocin covering its established obstetric uses, research into social and mental health applications, evidence limitations, and safety considerations.
A patient-facing reference guide to tirzepatide — a dual GIP/GLP-1 receptor agonist used for type 2 diabetes and weight management — covering its mechanism, approved uses, benefits, risks, and regulatory context.
A medical overview of BPC-157, a peptide often discussed for injury recovery and tissue repair, including research evidence and safety considerations.
A medical overview of GLP-1 receptor agonist medications used for weight loss and metabolic health, including semaglutide and tirzepatide.
An overview of peptide therapy, how peptide drugs work in the body, and the safety and regulatory issues surrounding these treatments.